Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment

PLoS ONE - Tập 6 Số 10 - Trang e26241
Soraya Carrancio1,2,3, Belén Blanco1,2,3, Carlos Romo1,2,3, Sandra Muntión2,3, Natalia López-Holgado2,3, Juan F. Blanco4, J G Briñón5, Jesús F. San Miguel1,2,3, Fermín Sánchez‐Guijo2,3, María Eugenia Fernández‐Santos1,2,3
1Centro de Investigación del Cáncer-IBMCC (Universidad de Salamanca-CSIC), Salamanca, Spain
2Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León and Red Nacional de Terapia Celular (Tercel, ISCIII), Castilla y León, Spain
3Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain
4Servicio de Traumatología, Hospital Universitario de Salamanca, Salamanca, Spain
5Departamento de Biologia Celular y Patologia, Universidad de Salamanca, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

RK Burt, 2008, Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?, J Autoimmun, 30, 116, 10.1016/j.jaut.2007.12.010

CV Jones, 2009, Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation., Future Oncol, 5, 559, 10.2217/fon.09.20

KC Myers, 2009, Hematopoietic stem cell transplantation for bone marrow failure syndromes in children., Biol Blood Marrow Transplant, 15, 279, 10.1016/j.bbmt.2008.11.037

S Koestenbauer, 2009, Protocols for hematopoietic stem cell expansion from umbilical cord blood., Cell Transplant, 18, 1059, 10.3727/096368909X471288

K Horvat-Karajz, 2009, In vitro effect of carboplatin, cytarabine, paclitaxel, vincristine, and low-power laser irradiation on murine mesenchymal stem cells., Lasers Surg Med, 41, 463, 10.1002/lsm.20791

A Spyridonidis, 2005, Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin., Stem Cells Dev, 14, 213, 10.1089/scd.2005.14.213

RW Garrett, 2009, Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches., Cell Stem Cell, 4, 503, 10.1016/j.stem.2009.05.011

S Janczewska, 2003, Fast hematopoietic recovery after bone marrow engraftment needs physiological proximity of stromal and stem cells., Cell Transplant, 12, 399, 10.3727/000000003108746948

J Renstrom, 2010, How the niche regulates hematopoietic stem cells., Chem Biol Interact, 184, 7, 10.1016/j.cbi.2009.11.012

K Kemp, 2010, Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy., Ann Hematol, 89, 701, 10.1007/s00277-009-0896-2

F Baron, 2010, Co-transplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following non-myeloablative conditioning., Biol Blood Marrow Transplant, 16, 838, 10.1016/j.bbmt.2010.01.011

SD Hiwase, 2009, Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice., Stem Cells, 27, 2293, 10.1002/stem.157

K Bartsch, 2009, Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used., Transplantation, 87, 217, 10.1097/TP.0b013e3181938998

JM Karp, 2009, Mesenchymal stem cell homing: the devil is in the details., Cell Stem Cell, 4, 206, 10.1016/j.stem.2009.02.001

EM Villaron, 2004, Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation., Haematologica, 89, 1421

M Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement., Cytotherapy, 8, 315, 10.1080/14653240600855905

B Guezguez, 2008, Transplantation of human hematopoietic repopulating cells: mechanisms of regeneration and differentiation using human-mouse xenografts., Curr Opin Organ Transplant, 13, 44, 10.1097/MOT.0b013e3282f42486

P Eliasson, 2010, The hematopoietic stem cell niche: low in oxygen but a nice place to be., J Cell Physiol, 222, 17, 10.1002/jcp.21908

I Garcia-Gomez, 2010, Mesenchymal stem cells: biological properties and clinical applications., Expert Opin Biol Ther, 10, 1453, 10.1517/14712598.2010.519333

S Fujita, 2008, Clonal analysis of hematopoiesis-supporting activity of human mesenchymal stem cells in association with Jagged1 expression and osteogenic potential., Cell Transplant, 17, 1169, 10.3727/096368908787236611

SD Hiwase, 2009, Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice., Stem Cells, 27, 2293, 10.1002/stem.157

S Carrancio, 2011, Bone marrow mesenchymal stem cells for improving hematopoietic function: An in vitro and in vivo model. Part 1: Effect on hematopoietic progenitors., PLoS ONE

J Grassinger, 2009, Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins., Blood, 114, 49, 10.1182/blood-2009-01-197988

MP Rettig, 2009, CXCR4 and mobilization of hematopoietic precursors., Methods Enzymol, 460, 57, 10.1016/S0076-6879(09)05203-3

WT Butler, 1989, The nature and significance of osteopontin., Connect Tissue Res, 23, 123, 10.3109/03008208909002412

A Sumitomo, 2010, The transcriptional mediator subunit MED1/TRAP220 in stromal cells is involved in hematopoietic stem/progenitor cell support through osteopontin expression., Mol Cell Biol, 30., 4818, 10.1128/MCB.01348-09

D Jing, 2010, Hematopoietic stem cells in coculture with mesenchymal stromal cells - modelling the niche compartments in vitro., Haematologica, 95, 542, 10.3324/haematol.2009.010736

S Mishima, 2010, Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent., Eur J Haematol, Jun;84, 538, 10.1111/j.1600-0609.2010.01419.x

T Ponomaryov, 2000, Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function., J Clin Invest, 106, 1331, 10.1172/JCI10329

S Mishima, 2010, Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent., Eur J Haematol

LM Ball, 2007, Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation., Blood, 110, 2764, 10.1182/blood-2007-04-087056

N Meuleman, 2009, Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study., Stem Cells Dev, 18, 1247, 10.1089/scd.2009.0029

CT van Velthoven, 2010, Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage., Pediatr Res, 68, 419

E Trouche, 2010, Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ., Cell Transplant, 19, 1623, 10.3727/096368910X514297

S Ikehara, 2005, Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders., Ann N Y Acad Sci, 1051, 626, 10.1196/annals.1361.107

PA Ramirez, 2010, Going straight to the point: intra-BM injection of hematopoietic progenitors., Bone Marrow Transplant, 45, 1127, 10.1038/bmt.2010.39

A Uccelli, 2008, Mesenchymal stem cells in health and disease., Nat Rev Immunol, 8, 726, 10.1038/nri2395

S Carrancio, 2008, Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification., Exp Hematol, 36, 1014, 10.1016/j.exphem.2008.03.012

MC Del Canizo, 2003, Immunophenotypic analysis of myelodysplastic syndromes., Haematologica, 88, 402

SD Clutter, 2006, Chemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells., Exp Hematol, 34, 1522, 10.1016/j.exphem.2006.06.021

LF Gibson, 1997, Disruption of bone marrow stromal cell function by etoposide., Biol Blood Marrow Transplant, 3, 122

N Lopez-Holgado, 2005, Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors., Haematologica, 90., 353

NC Gutierrez, 2004, Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma., Blood, 104, 2661, 10.1182/blood-2004-04-1319

C Gomez, 2007, Changes in the serotonergic system in the main olfactory bulb of rats unilaterally deprived from birth to adulthood., J Neurochem, 100, 924, 10.1111/j.1471-4159.2006.04229.x

B Blanco, 2006, Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines., Blood, 107, 3575, 10.1182/blood-2005-05-2118

J Gabert, 2003, Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program., Leukemia, 17, 2318, 10.1038/sj.leu.2403135

RM Hesselton, 1995, High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice., J Infect Dis, 172, 974, 10.1093/infdis/172.4.974